- Home
- DVS vs INNV Comparison
DVS vs INNV Comparison
Compare DVS & INNV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DVS | INNV |
|---|---|---|
| Founded | 2011 | 2007 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Nursing Services |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 409.7M | 485.4M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | DVS | INNV |
|---|---|---|
| Price | $4.70 | $4.99 |
| Analyst Decision | | Sell |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $5.00 |
| AVG Volume (30 Days) | ★ 846.9K | 246.1K |
| Earning Date | 11-13-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $884,662,000.00 |
| Revenue This Year | N/A | $11.18 |
| Revenue Next Year | N/A | $9.58 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 12.48 |
| 52 Week Low | $2.30 | $2.60 |
| 52 Week High | $5.38 | $6.26 |
Technical Indicators
Market Signals| Indicator | DVS | INNV |
|---|---|---|
| Relative Strength Index (RSI) | 63.23 | 48.23 |
| Support Level | $4.46 | $4.94 |
| Resistance Level | $4.78 | $5.21 |
| Average True Range (ATR) | 0.26 | 0.44 |
| MACD | 0.11 | -0.02 |
| Stochastic Oscillator | 84.05 | 17.42 |
Price Performance
Historical ComparisonAbout DVS Dolly Varden Silver Corporation Common Shares
Dolly Varden Silver Corp is a mineral exploration company. The company's primary business is the acquisition, exploration, evaluation, and development of exploration and evaluation assets. It is focused on exploration advancing the Kitsault Valley Project, which includes the Dolly Varden property and the Homestake Ridge property located in the Golden Triangle of British Columbia, Canada.
About INNV InnovAge Holding Corp.
InnovAge Holding Corp is a healthcare delivery platform by several participants focused on providing all-inclusive, capitated care to high-cost, dual-eligible seniors. Its patient-centered care delivery approach improves the quality of care while keeping them in their homes and reducing over-utilization of high-cost care settings such as hospitals and nursing homes. The company's segment includes PACE and others. It generates maximum revenue from the PACE segment.